Your browser doesn't support javascript.
loading
Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer.
Gibson, William J; Ruan, Daniel T; Paulson, Vera A; Barletta, Justine A; Hanna, Glenn J; Kraft, Stefan; Calles, Antonio; Nehs, Matthew A; Moore, Francis D; Taylor-Weiner, Amaro; Wala, Jeremiah A; Zack, Travis I; Lee, Thomas C; Fennessy, Fiona M; Alexander, Erik K; Thomas, Tom; Janne, Pasi A; Garraway, Levi A; Carter, Scott L; Beroukhim, Rameen; Lorch, Jochen H; Van Allen, Eliezer M.
Affiliation
  • Gibson WJ; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Ruan DT; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Paulson VA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Barletta JA; The Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts.
  • Hanna GJ; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Kraft S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Calles A; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Nehs MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Moore FD; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Taylor-Weiner A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wala JA; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Zack TI; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Lee TC; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Fennessy FM; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Alexander EK; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Thomas T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Janne PA; The Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts.
  • Garraway LA; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Carter SL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Beroukhim R; The Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts.
  • Lorch JH; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Van Allen EM; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
Clin Cancer Res ; 23(9): 2367-2373, 2017 May 01.
Article in En | MEDLINE | ID: mdl-27797976
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Genomics / Drug Synergism / Thyroid Carcinoma, Anaplastic Type of study: Systematic_reviews Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Genomics / Drug Synergism / Thyroid Carcinoma, Anaplastic Type of study: Systematic_reviews Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2017 Type: Article